Ottobock SE & Co. KGaA released its first quarter 2026 financials on Wednesday, showing a 4.4% increase in core sales versus the same quarter a year earlier and reaffirming its full-year outlook.
Core revenue for the quarter reached €378 million, up from €362.6 million in Q1 of the prior year. On an organic basis, core growth was reported at 5.1%.
Segment performance
The B2C segment expanded by 6.1% overall, with organic growth of 4.7%. Management cited the acquisitions of patient care businesses Matton and Northern Prosthetics as supporting factors for B2C momentum during the quarter.
The B2B segment advanced by 3.0%, and showed stronger organic underlying growth of 5.5%. The company highlighted demand strength in prosthetics and neuro-orthotics offerings, naming products such as Genium X4, Kenevo and C-Brace as drivers in that channel.
Profitability and margins
Underlying core EBITDA increased 11.8% year-on-year to €84.3 million, up from €75.5 million in the comparable quarter. The underlying core EBITDA margin rose to 22.3% from 20.8% the previous year. Ottobock attributed the margin improvement to product mix effects, procurement initiatives, operating leverage and cost discipline within administrative functions.
Regional revenue trends
By region, sales were up in EMEA by 8.1% and in APAC by 8.3%. Revenues in the Americas declined by 9.8%, with organic growth in that region reported as negative 1.1%. The company pointed to a strong comparison base in Q1 2025, temporarily weaker order intake from a large client and the impact of USD foreign exchange movements as the reasons for the Americas shortfall.
Outlook
Ottobock confirmed its 2026 guidance, expecting core business sales growth of between 5% and 8% and projecting an underlying core EBITDA margin above 26.5% for the year. The company also left unchanged its medium-term objectives through 2029, targeting organic growth of 7% to 9% and an underlying core EBITDA margin in the 29% to 30% range.
Contextual summary
The quarter combined modest top-line expansion with stronger profitability metrics, driven by a mix of acquisitions, product mix and internal cost measures. Regional performance was uneven, with double-digit declines in the Americas offset by solid growth in EMEA and APAC.